Chargement en cours...
Understanding silibinin’s modes of action against HCV using viral kinetic modeling
BACKGROUND & AIMS: Legalon® SIL (SIL) is a chemically hydrophilized version of silibinin that has exhibited high antiviral effectiveness against hepatitis C virus (HCV). Its main mode of action (MOA) remains unclear, with contradicting in-vitro studies supporting either suppression of entry and...
Enregistré dans:
| Auteurs principaux: | , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2012
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3328661/ https://ncbi.nlm.nih.gov/pubmed/22245888 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jhep.2011.12.012 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|